PAPER Exley C, Vickers T
SEARCH RESULTS
331007 RESULTS
PAPER Jin F, Gong QH, Xu YS, Wang LN, Jin H, Li F, Li LS, Ma YM, Shi JS
Icariin, a phosphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling.
Int J Neuropsychopharmacol. 2014 Jun;17(6):871-81. Epub 2014 Feb 11 PubMed: 24513083PAPER Xu PX, Wang SW, Yu XL, Su YJ, Wang T, Zhou WW, Zhang H, Wang YJ, Liu RT
Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation.
Behav Brain Res. 2014 May 1;264:173-80. Epub 2014 Feb 7 PubMed: 24512768PAPER Mendiratta P, Wei JY
Diagnosing Alzheimer's disease: update for the primary care clinician.
J Ark Med Soc. 2014 Jan;110(8):160-3. PubMed: 24511859PAPER Fujiwara N, Shimizu J, Takai K, Arimitsu N, Saito A, Kono T, Umehara T, Ueda Y, Wakisaka S, Suzuki T, Suzuki N
Restoration of spatial memory dysfunction of human APP transgenic mice by transplantation of neuronal precursors derived from human iPS cells.
Neurosci Lett. 2013 Oct 25; PubMed: 24513296PAPER Favier M, Duran T, Carcenac C, Drui G, Savasta M, Carnicella S
Pramipexole reverses Parkinson's disease-related motivational deficits in rats.
Mov Disord. 2014 Jun;29(7):912-20. Epub 2014 Feb 11 PubMed: 24515412PAPER Abe K, Karlawish JH
Cognitive impairment and PD patients' capacity to consent to research.
Neurology. 2014 Feb 11;82(6):546. PubMed: 24514011PAPER
Mild cognitive impairment.
J Int Neuropsychol Soc. 2014 Feb;20(2) PubMed: 24512672PAPER Mandas A, Congiu MG, Abete C, Dessi S, Manconi PE, Musio M, Columbu S, Racugno W
Cognitive decline and depressive symptoms in late-life are associated with statin use: evidence from a population-based study of Sardinian old people living in their own home.
Neurol Res. 2014 Mar;36(3):247-54. PubMed: 24512018PAPER Rotblat B, Southwell AL, Ehrnhoefer DE, Skotte NH, Metzler M, Franciosi S, Leprivier G, Somasekharan SP, Barokas A, Deng Y, Tang T, Mathers J, Cetinbas N, Daugaard M, Kwok B, Li L, Carnie CJ, Fink D, Nitsch R, Galpin JD, Ahern CA, Melino G, Penninger JM, Hayden MR, Sorensen PH
HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response.
Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3032-7. Epub 2014 Feb 10 PubMed: 24516159PAPER Thenganatt MA, Jankovic J
Parkinson disease subtypes.
JAMA Neurol. 2014 Apr;71(4):499-504. PubMed: 24514863PAPER Perales J, Cosco TD, Stephan BC, Fleming J, Martin S, Haro JM, Brayne C, CC75C Study
Health-related quality of life in the Cambridge City over-75s Cohort (CC75C): development of a dementia-specific scale and descriptive analyses.
BMC Geriatr. 2014 Feb 10;14:18. PubMed: 24512291PAPER Zhang D, Bordia T, McGregor M, McIntosh JM, Decker MW, Quik M
ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease.
Mov Disord. 2014 Apr;29(4):508-17. Epub 2014 Feb 11 PubMed: 24515328PAPER Tanner CM, Meng CC, Ravina B, Lang A, Kurlan R, Marek K, Oakes D, Seibyl J, Flagg E, Gauger L, Guest DD, Goetz CG, Kieburtz K, Dieuliis D, Fahn S, Elliott RA, Shoulson I
A practical approach to remote longitudinal follow-up of Parkinson's disease: The FOUND study.
Mov Disord. 2014 Feb 11; PubMed: 24515275PAPER Meier B, Weiermann B, Gutbrod K, Stephan MA, Cock J, Müri RM, Kaelin-Lang A
Implicit task sequence learning in patients with Parkinson's disease, frontal lesions and amnesia: The critical role of fronto-striatal loops.
Neuropsychologia. 2013 Oct 24; PubMed: 24513443Current Filters
No filters selected